已收盤 10-24 16:00:00 美东时间
+0.380
+4.51%
Novartis' Cosentyx Phase 3 REPLENISH trial for polymyalgia rheumatica met primary and secondary endpoints, showing significant sustained remission.
10-23 02:35
广船国际技术暴涨逾155%!AI芯片性能媲美主流图形处理器;“人造肉”公司BYND大涨超127%,将近11.5亿美元零息可转换债券置换成新的资产组合>>
10-21 14:37
今日重点评级关注:Maxim Group:维持Rani Therapeutics Hldgs"买入"评级,目标价从5美元升至10美元;韦德布什:维持Corbus Pharmaceuticals"跑赢大市"评级,目标价从31美元升至38美元
10-21 18:13
An update from Replimune Group ( ($REPL) ) is now available. On October 20, 202...
10-21 02:50
Shares of Replimune Group are rising Monday after the clinical stage biotechnology company shared an important regulatory update.
10-21 00:14
U.S. stocks were higher, with the Nasdaq Composite gaining more than 1% on Mond...
10-20 22:13
Wedbush analyst Robert Driscoll upgrades Replimune Group (NASDAQ:REPL) from Neutral to Outperform and raises the price target from $4 to $18.
10-20 21:09
Gainers Replimune Group (NASDAQ:REPL) stock increased by 95.3% to $8.79 during...
10-20 20:08
REPL: 81% | The FDA Accepts Replimune's Resubmission Of The Biologics License Application For RP1 In Combination With Nivolumab For Advanced Melanoma, PDUFA Date Is April 10, 2026 DVLT: 20% | Datavault AI
10-20 19:36
(来源:中化新网) 中化新网讯 卡博特公司近日发布《2025年可持续发展报告》,阐述了公司2024年在推进可持续发展绩效、实现关键目标方面所取得的进展。报告...
10-20 11:38